EUDA: Deutschland und die Niederlande sind die Länder mit den höchsten Cannabinoidkonzentrationen im Abwasser. Die Europäische Arzneimittelbehörde (EUDA) veröffentlichte diese Woche die Ergebnisse der neuesten Studie „Abwasser- und Arzneimittelanalyse – eine europäische Multicenterstudie“, die in Zusammenarbei...

EUDA: Deutschland und die Niederlande sind die Länder mit den höchsten Cannabinoidkonzentrationen im Abwasser – CannaReporter

Die Europäische Agentur #EUDA hat die Ergebnisse einer aktuellen Studie veröffentlicht, die den Konsum von #Drogen in #Europa untersucht.

cannareporter.eu/de/2026/03/2...

Halterna av bland annat kokain och cannabis har minskat i avloppsvattnet i flera svenska städer - det visar årets analys från EU:s narkotikamyndighet #EUDA
www.alkoholochnarkotika.se/prevention/m...

EUDA Announces Reverse Stock Split of its Ordinary Shares EUDA Health Holdings (NASDAQ: EUDA) will implement a 1-for-20 reverse stock split, effective at market open on March 23, 2026. The split was approved by the board under British Virgin Islands law and the post-split CUSIP will be G3142E147.Outstanding shares are expected to convert from approximately 50,307,491 to about 2,515,375 shares. Warrants will be adjusted proportionately: aggregate warrants remain 8,917,250, reducing issuable shares from 4,458,625 to about 222,932, and the warrant exercise price will change from $11.50 (per half-share basis) to $230.00 per warrant. No fractional shares or cash will be issued for fractions; holdings will be rounded up.

#EUDA EUDA Announces Reverse Stock Split of its Ordinary Shares

www.stocktitan.net/news/EUDA/euda-announces...

La #HealthyNightlifeToolbox de la #EUDA es un recurso para apoyar la #prevención y la #ReducciónDeDaños asociados al consumo de #alcohol y #drogas en entornos de #ocio nocturno. Reúne intervenciones, evidencia y literatura especializada para orientar la acción pública y profesional.
🔧 bit.ly/4ux7BZs

EUDA Health Holdings Limited Announces Repurchase and Cancellation of Streeterville Warrant EUDA Health Holdings (NASDAQ: EUDA) repurchased and cancelled in full a warrant issued to Streeterville Capital, eliminating the potential issuance of up to 2,000,000 ordinary shares. The warrant was repurchased on February 27, 2026 for a total purchase price of US$125,000.As a result, there are no warrants remaining under the November 26, 2025 securities purchase agreement and the related potential dilution has been fully removed.

#EUDA EUDA Health Holdings Limited Announces Repurchase and Cancellation of Streeterville Warrant

www.stocktitan.net/news/EUDA/euda-health-ho...

EUDA Health Announces Second Amendment to Streeterville Warrant Agreement EUDA Health (NASDAQ: EUDA) announced a second amendment to its Streeterville warrant agreement dated January 13, 2026. The amendment reduces the warrant exercise price from US$4.00 to US$2.00 and lowers the forced-exercise minimum closing price from US$6.00 to US$3.00. All other warrant terms remain unchanged. Management described the change as a technical adjustment to align terms with current market conditions while preserving capital-structure flexibility and maintaining the company’s strategic focus on preventive health, longevity, and personalised healthcare.

#EUDA EUDA Health Announces Second Amendment to Streeterville Warrant Agreement

www.stocktitan.net/news/EUDA/euda-health-an...

EUDA Enters into Convertible Loan Agreement with Shenzhen Inno, Further Expanding Stem Cell Therapy Platform EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the “Company”), a Singapore based non-invasive healthcare provider in Asia focused on Singapore, Malaysia and China, today announced that its wholly owned subsidiary, EUDA Health Pte. Ltd. (“EUDA

#EUDA EUDA Enters into Convertible Loan Agreement with Shenzhen Inno, Further Expanding Stem Cell Therapy Platform

www.stocktitan.net/news/EUDA/euda-enters-in...

EUDA Health Holdings Limited Announces Amendment to Streeterville Warrant Agreement EUDA Health Holdings Limited (NASDAQ: EUDA) “EUDA” or “the Company”, a Singapore-based non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and China, today announced that it has entered into an amendment (the “Warrant Amendment”)

#EUDA EUDA Health Holdings Limited Announces Amendment to Streeterville Warrant Agreement

www.stocktitan.net/news/EUDA/euda-health-ho...

EUDA Launches Nationwide Stem Cell Extraction, Cryostorage and Clinical Delivery Platform in China with Shenzhen Inno Immune and Wuhan Kaien Hospital EUDA (NASDAQ: EUDA) announced on December 30, 2025 the launch of a nationwide stem cell extraction, cryostorage and clinical delivery platform in China in partnership with Shenzhen Inno Immune and Wuhan Kaien Hospital. The platform combines centralized processing with decentralized clinical access, cold-chain logistics and integration into longevity medicine.Key infrastructure includes an initial ~50,000 patient-unit cryogenic hub in Shenzhen and a planned ~200,000 patient-unit capacity at Wuhan Kaien, plus a partner network of extraction clinics and regulated transport for sample movement and clinical delivery.

#EUDA EUDA Launches Nationwide Stem Cell Extraction, Cryostorage and Clinical Delivery Platform in China with Shenzhen Inno Immune and Wuhan Kaien Hospital

www.stocktitan.net/news/EUDA/euda-launches-...

EUDA Health to Launch EUDA Helixé 2.0 in January 2026 EUDA Health Holdings Limited (NASDAQ: EUDA) “EUDA” or “the Company”, a Singapore-based non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and China, today announced that it will launch EUDA Helixé 2.0 in January 2026, marking the

#EUDA EUDA Health to Launch EUDA Helixé 2.0 in January 2026

www.stocktitan.net/news/EUDA/euda-health-to...

EUDA Accelerates Longevity Strategy with Launch of Stem Cell Platform and First Longevity Clinic in Shenzhen EUDA Health Holdings Ltd. (Nasdaq: EUDA) announced a strategic expansion of its regenerative medicine and longevity business with the launch of a comprehensive

EUDA #EUDA Accelerates Longevity Strategy with Launch of Stem Cell Platform and First Longevity Clinic in Shenzhen
prismmarketview.com/euda-acceler...

EUDA Accelerates Longevity Strategy with Launch of Comprehensive Stem Cell Therapy Platform and First Clinic in Shenzhen EUDA Health Holdings Limited (NASDAQ: EUDA) “EUDA” or “the Company”, a Singapore-based non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and China, today announced a significant acceleration of its longevity and regenerative

#EUDA EUDA Accelerates Longevity Strategy with Launch of Comprehensive Stem Cell Therapy Platform and First Clinic in Shenzhen

www.stocktitan.net/news/EUDA/euda-accelerat...

EUDA Integrates QB Utility Token to Create a Digital Health and Rewards Platform Across Its Healthcare Ecosystem EUDA Health Holdings Limited (NASDAQ: EUDA) “EUDA” or “the Company”, a Singapore-based non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and China, today announced a strategic technology integration that would introduce the QB

#EUDA EUDA Integrates QB Utility Token to Create a Digital Health and Rewards Platform Across Its Healthcare Ecosystem

www.stocktitan.net/news/EUDA/euda-integrate...

Por qué Berta Vázquez reabre el tabú de la cocaína: qué dijo El alegato de Berta Vázquez sobre la cocaína sacude redes y agenda pública: normalización, cifras en España, ley y recursos para pedir ayuda. La actriz Berta Vázquez ha encendido un debate que llevaba...

Por qué Berta Vázquez reabre el tabú de la cocaína: qué dijo #BertaVazquez #cocaina #adicciones #consumo #Espana #SaludPublica #Debate #RedesSociales #Ley4_2015 #PlanNacionalSobreDrogas #EDADES2024 #EUDA #EuropeanDrugReport #16dediciembre #felizmartes
donporque.com/berta-vazque...

EUDA Plans to Integrate QB Utility Token into Its Healthcare Ecosystem EUDA Health Holdings (NASDAQ: EUDA) announced plans to integrate a third‑party utility cryptocurrency called QB into its digital health and rewards platform, with QB scheduled for launch in January 2026. The token will be usable across EUDA’s ecosystem for payments, rewards, and access to healthcare products and partner services in Singapore, Malaysia, and China. EUDA also plans to hold QB in its digital asset treasury to support long‑term financial flexibility and participation in blockchain initiatives. The initiative aims to link healthcare engagement with decentralized finance to enhance loyalty, access, and community participation.

#EUDA EUDA Plans to Integrate QB Utility Token into Its Healthcare Ecosystem

www.stocktitan.net/news/EUDA/euda-plans-to-...

EUDA Health Holdings Limited Announces Execution of Securities Purchase Agreement EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or “the Company”), a Singapore-based non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and China, today announced that it entered into a securities purchase agreement on

#EUDA EUDA Health Holdings Limited Announces Execution of Securities Purchase Agreement

www.stocktitan.net/news/EUDA/euda-health-ho...

## Un'analisi completa dei comportamenti di consumo di sostanze tra gli adolescenti in tutta Europa


Il rapporto ESPAD 2024 “School Survey on Alcohol and Other Drugs”, pubblicato recentemente da #EUDA (l’ Agenzia dell'Unione europea sulle droghe il cui […]

[Original post on poliverso.org]

EUDA Subsidiary CK Health Plus Expands into India in Strategic Partnership with SafeRock India EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the “Company”), a Singapore-based non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and China, today announced that its wholly-owned subsidiary, CK Health Plus Sdn. Bhd. (“CK

#EUDA EUDA Subsidiary CK Health Plus Expands into India in Strategic Partnership with SafeRock India

www.stocktitan.net/news/EUDA/euda-subsidiar...

EUDA Subsidiary CK Health Plus Secures Malaysia Direct Selling License, Strengthening Its Longevity Business Across Asia EUDA Health Holdings (NASDAQ: EUDA) announced on October 20, 2025 that its wholly owned subsidiary CK Health Plus received a Malaysian Direct Selling License (AJL 932509) from the Ministry of Domestic Trade and Cost of Living.The License authorizes nationwide direct selling and multi-level marketing activities, including member recruitment, distribution of EUDA Helixé supplements, and operation of Bioenergy Capsule Centers. CK Health Plus said it will roll out centers and expand its agent network across Malaysia and strengthen synergies with Singapore operations while providing product training to agents to ensure ethical wellness education.

#EUDA EUDA Subsidiary CK Health Plus Secures Malaysia Direct Selling License, Strengthening Its Longevity Business Across Asia

www.stocktitan.net/news/EUDA/euda-subsidiar...

**L'Agenzia antidroga dell'Unione Europea si rafforza e punta sempre di più sulla cooperazione internazionale**

##

L'EUDA (in precedenza nota come Osservatorio europeo delle Droghe e delle Tossicodipendenze, EMCDDA) è l'Agenzia dell'Unione europea sulle […]

[Original post on poliverso.org]

Apple pushes back on EU's Digital Markets Act, aimed at curbing tech giants' power Apple has intensified its pushback against the EU's Digital Markets Act, claiming it compromises user security and delays innovation. Discover why Apple argues the landmark law disrupts the seamless experience consumers expect.

Apple pushes back on EU’s Digital Markets Act, aimed at curbing tech giants’ power The EU’s Digital Markets Act: A Landmark Law Shaping Digital Competition In 2022, the European.... @cosmicmeta.ai #EUDA

https://u2m.io/c7lLOdhE

Cárteles mexicanos en Polonia: cocinas de metanfetamina y alianzas con mafias locales - Cárteles mexicanos expanden operaciones en Polonia con laboratorios de metanfetamina y apoyo de redes locales. Europol y EUDA alertan por auge de sintéticos.

Los cárteles mexicanos ya operan “cocinas” en Polonia con apoyo local. Caen laboratorios, suben los sintéticos y Europa enciende alarmas. 
https://f.mtr.cool/bswgszcedv
#PolíticaGurú  #Metanfetamina #Carteles #Europol #EUDA

EUDA Signs Letter of Intent to Potentially Acquire GO POSB EUDA Health Holdings (NASDAQ: EUDA), a Singapore-based healthcare provider, has signed a Letter of Intent to potentially acquire GO POSB Organoids, a Singapore biotechnology company. GO POSB has developed a proprietary induced pluripotent stem cell (iPSC) platform that converts human blood cells into clinical-grade stem cells.The companies plan to establish an iPSC laboratory and cultivation facility in Shenzhen, China, collaborating with Singapore's A*STAR for research and clinical trials. The facility aims to serve as a distribution hub for iPSC solutions across China, pending regulatory approvals. The initiative aligns with EUDA's strategy to expand its stem cell treatments and supplements portfolio.

#EUDA EUDA Signs Letter of Intent to Potentially Acquire GO POSB

www.stocktitan.net/news/EUDA/euda-signs-let...

$8,000 T-Cell Immunotherapy: EUDA Brings Breakthrough Treatment to Malaysia at Fraction of Market Cost Singapore-based EUDA Health expands cell therapy portfolio with Malaysian distribution rights for Shenzhen Inno's T-cell immunotherapies. GMP-certified treatment priced at $8,000, marking second major cell therapy deal of 2025.

#EUDA EUDA Strategically Expands into T-Cell Immunotherapy – Strengthening Its Stem Cell Therapy Portfolio

www.stocktitan.net/news/EUDA/euda-strategic...

**31 agosto, Giornata internazionale di sensibilizzazione sull'overdose: in Europa preoccupa la cocaina**

L' #overdose continua a mietere migliaia di vittime in Europa, sottolineando la necessità di un'azione urgente. La Giornata internazionale di […]

[Original post on poliverso.org]

Singapore Biotech Deal: EUDA Health to Acquire Chemokine, Creator of Gene-Modulating Immune Supplement Singapore-based EUDA Health plans to acquire Chemokine Pte Ltd with 120-day exclusivity period. Deal includes Euda Helixé supplement with molecular deer placenta and gene activation technology.

#EUDA EUDA Signs Letter of Intent to Potentially Acquire Chemokine Pte Ltd

www.stocktitan.net/news/EUDA/euda-signs-let...

Revolutionary Gene-Activating Immune Supplement: EUDA Gains Worldwide Rights to Breakthrough Formula Singapore healthcare provider EUDA acquires worldwide distribution rights for Euda Helixé, an epigenetic immune supplement. Projects 500K bottle sales in first year across Asia markets.

#EUDA EUDA Expands Wellness Product Portfolio With A Next-Generation Immune Health Supplement

www.stocktitan.net/news/EUDA/euda-expands-w...

#HepatitisB & #HepatitisC affect millions in Europe - people in prisons are especially affected.

The #EuroHePP toolkit from @ecdc.europa.eu & #EUDA helps health services to assess local needs & gaps, plan a strategy & implement services to eliminate hepatitis in prisons.

#IDsky #EpiSky #Hepatitis

#EuroHePP – a new interactive toolkit from #ECDC & #EUDA designed to support efforts to eliminate hepatitis B & C in prisons in Europe.

It offers guidance for:
✅ Conducting a health needs assessment
✅ Strategy development
✅ Service implementation
✅ Monitoring & evaluation

eurohepp.ecdc.europa.eu

🚨 ¿Buscas prácticas en Europa? La Agencia Antidroga de la UE te espera en Lisboa para adquirir experiencia y conocimientos sobre el trabajo de esta agencia de la UE. 🇵🇹

🔗https://lc.cx/sZmbQ-

#Convocatoria #Eurodesk #Prácticas #AgenciaAntidroga #EUDA #Lisboa #Portugal